Why is Arcellx stock up 80% today? Gilead’s $7.8B answer
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.
Fridays used to be reserved for routine headlines. But since Donald Trump’s reelection, every Friday seems like a bombshell day. And last Friday
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its
The token remains 50.07% down from the all-time high of $59.39 hit in September last year. The technical indicator shows the first resistance
Ethereum is trading around the $2,020 zone. The ETH market has experienced liquidations worth $85.29M. Within the market-wide price suppression, some of the
The meteoric rise of artificial intelligence, which once propelled markets to record highs, has hit a wall of skepticism. In early February 2026,